Constructing inverse probability weights for marginal structural models
- PMID: 18682488
- PMCID: PMC2732954
- DOI: 10.1093/aje/kwn164
Constructing inverse probability weights for marginal structural models
Abstract
The method of inverse probability weighting (henceforth, weighting) can be used to adjust for measured confounding and selection bias under the four assumptions of consistency, exchangeability, positivity, and no misspecification of the model used to estimate weights. In recent years, several published estimates of the effect of time-varying exposures have been based on weighted estimation of the parameters of marginal structural models because, unlike standard statistical methods, weighting can appropriately adjust for measured time-varying confounders affected by prior exposure. As an example, the authors describe the last three assumptions using the change in viral load due to initiation of antiretroviral therapy among 918 human immunodeficiency virus-infected US men and women followed for a median of 5.8 years between 1996 and 2005. The authors describe possible tradeoffs that an epidemiologist may encounter when attempting to make inferences. For instance, a tradeoff between bias and precision is illustrated as a function of the extent to which confounding is controlled. Weight truncation is presented as an informal and easily implemented method to deal with these tradeoffs. Inverse probability weighting provides a powerful methodological tool that may uncover causal effects of exposures that are otherwise obscured. However, as with all methods, diagnostics and sensitivity analyses are essential for proper use.
References
-
- Robins JM. 1997 proceedings of the American Statistical Association, Section on Bayesian Statistical Science. Alexandria, VA: American Statistical Association; 1998. Marginal structural models; pp. 1–10. ( http://biosun1.harvard.edu/∼robins/msm-web.pdf)
-
- Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550–60. - PubMed
-
- Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561–70. - PubMed
-
- Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the joint causal effect of non-randomized treatments. J Am Stat Assoc. 2001;96:440–8.
Publication types
MeSH terms
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- R01-AI073127/AI/NIAID NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- 5-MO1-RR-00722/RR/NCRR NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- R01 AI073127/AI/NIAID NIH HHS/United States
- UO1-AI-37984/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- R03 AI071763/AI/NIAID NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
- R03-AI071763/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- AI-34989/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- UO1-AI-37613/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials